{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:00:07Z","timestamp":1791658807095,"version":"4.3.4"},"reference-count":33,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:p>Objective.\u2014To compare tramadol\/acetaminophen (APAP) and placebo for the management of acute migraine pain.<\/jats:p>\n                  <jats:p>Background.\u2014Tramadol\/APAP tablets reduced moderate\u2010to\u2010moderately severe acute pain in controlled studies of other painful conditions.<\/jats:p>\n                  <jats:p>Methods.\u2014This randomized, double\u2010blind, placebo\u2010controlled, parallel group study enrolled adults with migraine pain as per International Headache Society criteria. Subjects took tramadol\/APAP (total dose, 75 mg\/650 mg) or placebo for a typical migraine with moderate\u2010to\u2010severe pain. Severity of pain and migraine\u2010related symptoms were recorded before study medication and at 0.5, 1, 2, 3, 4, 6, and 24 hours after study medication.<\/jats:p>\n                  <jats:p>\n                    Results.\u2014Efficacy analyses included 305 subjects (154 tramadol\/APAP and 151 placebo). Treatment response was higher for tramadol\/APAP than a placebo at 2 hours after dosing (55.8% vs. 33.8%,\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .001) and at every other assessment from 30 minutes (12.3% vs. 6.6%) through 6 hours (64.9% vs. 37.7%) (all\n                    <jats:italic>P<\/jats:italic>\n                    \u2264 .022). Subjects in the tramadol\/APAP group were more likely than those in the placebo group to be pain\u2010free at 2 hours (22.1% vs. 9.3%), 6 hours (42.9% vs. 25.2%), and 24 hours (52.7% vs. 37.9%) (all\n                    <jats:italic>P<\/jats:italic>\n                    \u2264 .007). Two hours after dosing, moderate\u2010to\u2010severe symptoms that were less common for tramadol\/APAP than placebo included photophobia (34.6% vs. 52.2%,\n                    <jats:italic>P<\/jats:italic>\n                    = .003) and phonophobia (34.3% vs. 44.9%,\n                    <jats:italic>P<\/jats:italic>\n                    = .008), but not migraine\u2010related nausea (38.5% vs. 29.4%,\n                    <jats:italic>P<\/jats:italic>\n                    = .681). Treatment\u2010related adverse events included nausea, dizziness, vomiting, and somnolence.\n                  <\/jats:p>\n                  <jats:p>Conclusions.\u2014Tramadol\/APAP reduces the severity of pain, photophobia, and phonophobia associated with migraine headache, but does not reduce migraine\u2010associated nausea. Tramadol\/APAP might be an appropriate option for the management of moderate\u2010to\u2010severe migraine headache.<\/jats:p>","DOI":"10.1111\/j.1526-4610.2005.00264.x","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T10:06:47Z","timestamp":1281694007000},"page":"1317-1327","source":"Crossref","is-referenced-by-count":39,"title":["Tramadol\/Acetaminophen for the Treatment of Acute Migraine Pain: Findings of a Randomized, Placebo\u2010Controlled Trial"],"prefix":"10.1111","volume":"45","author":[{"given":"Stephen D.","family":"Silberstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick G.","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd D.","family":"Rozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Kudrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman R.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the CAPSS\u2010223 Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,11]]},"reference":[{"key":"e_1_2_7_3_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.041007638.x"},{"key":"e_1_2_7_3_3_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.4.494.32124"},{"key":"e_1_2_7_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(02)00024-6"},{"key":"e_1_2_7_3_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00404.x"},{"key":"e_1_2_7_3_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200326020-00003"},{"key":"e_1_2_7_3_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-10-200211190-00014"},{"key":"e_1_2_7_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(01)00320-7"},{"key":"e_1_2_7_3_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1991.tb03598.x"},{"key":"e_1_2_7_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1995.hed3502065.x"},{"key":"e_1_2_7_3_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3807516.x"},{"key":"e_1_2_7_3_12_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1976.tb141126.x"},{"key":"e_1_2_7_3_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006058701500202"},{"key":"e_1_2_7_3_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1994.1402156.x"},{"key":"e_1_2_7_3_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.6.754"},{"key":"e_1_2_7_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)11227-5"},{"key":"e_1_2_7_3_17_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(24)38900-1","article-title":"Discovery of \u201cself\u2010synergistic\u201d spinal\/supraspinal antinociception produced by acetaminophen (paracetamol)","volume":"295","author":"Raffa RB","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_3_18_2","first-page":"PL 23","article-title":"Testing for synergism over a range of fixed ratio drug combinations: Replacing the isobologram","volume":"58","author":"Tallarida RJ","year":"1996","journal-title":"Life Sci"},{"key":"e_1_2_7_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(01)00404-3"},{"key":"e_1_2_7_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.01.004"},{"key":"e_1_2_7_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)85024-X"},{"key":"e_1_2_7_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2004.52108.x"},{"key":"e_1_2_7_3_23_2","first-page":"79","article-title":"Tramadol and acetaminophen tablets for dental pain","volume":"48","author":"Medve RA","year":"2001","journal-title":"Anesth Prog"},{"key":"e_1_2_7_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80010-8"},{"key":"e_1_2_7_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2003.12.038"},{"key":"e_1_2_7_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80118-1"},{"key":"e_1_2_7_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(99)00041-1"},{"issue":"7","key":"e_1_2_7_3_28_2","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8","author":"Headache Classification Committee of the International Headache Society","year":"1988","journal-title":"Cephalalgia"},{"key":"e_1_2_7_3_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200203000-00003"},{"key":"e_1_2_7_3_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6977.452"},{"key":"e_1_2_7_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15440-8"},{"key":"e_1_2_7_3_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.7.1011"},{"key":"e_1_2_7_3_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.041007646.x"},{"key":"e_1_2_7_3_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00528.x"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1526-4610.2005.00264.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1526-4610.2005.00264.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:58:15Z","timestamp":1762081095000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/j.1526-4610.2005.00264.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1111\/j.1526-4610.2005.00264.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4610.2005.00264.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}